Filing Details

Accession Number:
0001209191-21-003921
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-01-15 20:29:32
Reporting Period:
2021-01-14
Accepted Time:
2021-01-15 20:29:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1787297 Passage Bio Inc. PASG Biological Products, (No Disgnostic Substances) (2836) 822729751
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1799780 M. Jill Quigley Two Commerce Square
200 Market Street, 28Th Floor
Philadelphia PA 19103
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-01-14 16,298 $30.10 296,584 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,000 Indirect By Spouse
Footnotes
  1. The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.64, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
  3. Represents 296,584 shares of common stock, of which 148,534 shares are unvested and subject to repurchase by the Issuer if the reporting person ceases to provide services to the Issuer prior to the vesting of the shares.
  4. Includes 1,388 shares acquired under the 2020 Employee Stock Purchase Plan on November 15, 2020.